Debut Plus

₹1,138.95

▲ +5.22 +0.46%

10 Sept 2026

NSE Listed

Symbiotec Pharmalab Ltd. (SYMBIOTEC)

Volume: 21,10,809Avg Vol 1W: 21,57,396Avg Vol 1M: 63,51,17052W Range:₹934.2₹1,193.7
NSE BSE www.symbiotec.com
Key Ratios
Checked 3h ago
Market Cap₹7,415 Cr
Current Price₹1,138.95
Previous Close₹1,133.73
High / Low (52w)₹1,193.7 / ₹934.2
Volume21,10,809
Avg Vol (1W)21,57,396
Avg Vol (1M)63,51,170
Stock P/E64.29
Book Value₹202.32
Dividend Yield0%
ROE9.56%
ROA187.19%
Revenue (TTM)—
Revenue Growth—
Profit Margin14.73%
Total Debt—
Shares Outstanding6 Cr
Face Value—
EPS (TTM)₹17.95
P/B5.7
Debt / Equity0.48
50 DMA—
200 DMA—
Day change+0.46%
Price Chart
₹1,138.95▲ 3.76% · 1Y
₹1139₹10773.0Cr
2026-09-01
2026-09-10

20-day avg volume: 63.5L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 15% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 64.
Quarterly Results
MetricJun 2025
Revenue₹203 Cr
EBITDA₹50 Cr
Net Profit₹30 Cr
EPS—
Profit & Loss (Annual)
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹640 Cr₹685 Cr₹573 Cr₹723 Cr₹756 Cr₹872 Cr
EBITDA₹178 Cr₹107 Cr₹47 Cr₹140 Cr₹163 Cr₹188 Cr
Net Profit₹123 Cr₹78 Cr₹23 Cr₹100 Cr₹97 Cr₹110 Cr
EPS1137121.4891.4988.519
Balance Sheet
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹768 Cr₹815 Cr₹990 Cr₹1,295 Cr₹1,580 Cr₹1,781 Cr
Total Liabilities₹248 Cr₹217 Cr₹369 Cr₹580 Cr₹765 Cr₹631 Cr
Equity₹521 Cr₹599 Cr₹621 Cr₹715 Cr₹815 Cr₹1,150 Cr
Total Debt——————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹217 Cr₹47 Cr₹87 Cr₹222 Cr₹82 Cr₹236 Cr
Investing₹-96 Cr₹-32 Cr₹-220 Cr₹-206 Cr₹-307 Cr₹-227 Cr
Financing₹-79 Cr₹15 Cr₹146 Cr₹22 Cr₹278 Cr₹36 Cr
Free Cash Flow₹217 Cr₹47 Cr₹87 Cr₹222 Cr₹82 Cr₹236 Cr
Shareholding
Promoter 33.28% Institutions 48.6% Public 18.12%
Efficiency & Working Capital
ROCE11.6%
Interest Coverage6.9
Dividend Payout—
Debtor Days83 d
Inventory Days99 d
Payable Days58 d
Cash Conversion Cycle124 d
Working Capital Days182 d
Shareholding Details

As of 2026-08-31

Promoter33.3%
FII21.1%
DII27.5%
Institutions48.6%
Public18.1%
Promoter Pledge0%
No. of Shareholders4,27,730
Shareholding Pattern

Quarterly — figures in %. Latest 2 quarters.

PeriodDec 2025Aug 2026
Promoters35.1%33.3%
FIIs0%21.1%
DIIs0%27.5%
Public64.9%18.1%
Promoter Pledge0%0%
No. of Shareholders154,27,730
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Satwani Holdings LlpShareholding of Promoter and Promoter Group15.3%98,19,885
Rosewood InvestmentsPublic Shareholding14.1%90,42,092
Business Excellence Trust Iii - India Business Excellence Fund IiiPublic Shareholding10.2%65,78,995
Anil SatwaniShareholding of Promoter and Promoter Group4.4%28,10,896
Kashish SatwaniShareholding of Promoter and Promoter Group4.3%27,50,896
Krishna Anil Satwani Family TrustShareholding of Promoter and Promoter Group3.4%21,99,104
Arjun Anil Satwani Family TrustShareholding of Promoter and Promoter Group3.4%21,99,104
Valuequest Founders Conviction LvfPublic Shareholding2.9%18,76,291
Think India Opportunities Master Fund LpPublic Shareholding2.8%17,71,255
Sushil SatwaniShareholding of Promoter and Promoter Group1.9%12,33,938
Dymon Asia Multi-strategy Investment (singapore) Pte. LtdPublic Shareholding1.6%10,12,145
Icici Prudential Smallcap FundPublic Shareholding1%6,62,459
Kashish And Anil Satwani Family TrustShareholding of Promoter and Promoter Group0.5%3,50,000
Sunil SatwaniShareholding of Promoter and Promoter Group0%10,000
Swati SachdevShareholding of Promoter and Promoter Group0%10,000
Manohar SatwaniShareholding of Promoter and Promoter Group0%0
Lekhraj RajwaniShareholding of Promoter and Promoter Group0%0
Arjun SatwaniShareholding of Promoter and Promoter Group0%0
Krishna SatwaniShareholding of Promoter and Promoter Group0%0
Kamla PagaraniShareholding of Promoter and Promoter Group0%0
Seemaben Rupchand BhagwaniShareholding of Promoter and Promoter Group0%0
Anita JashnaniShareholding of Promoter and Promoter Group0%0
Rekha Raju SambhwaniShareholding of Promoter and Promoter Group0%0
Tejasvee SatwaniShareholding of Promoter and Promoter Group0%0
Dhanraaj SatwaniShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
ANIL KUMAR SATWANIManaging Director2021
SHANKAR GOPALAKRISHNANNominee2021
VISWANATH VENKATA SUBRAHMANYA ANJANEYA CHIBROLUNominee2021
SUMIT GUPTANominee2021
ROHIT BRIJMOHAN MANTRINominee2021
Salil JainCompany Secretary2021
Segments — Geography
RegionRevenueShare
India₹342 Cr45.2%
Outside india₹415 Cr54.8%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10301111
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202421700011227
20241990000199
202450001115
Company Information
Incorporated2002
AuditorSRBC & Co LLP
Investor Email[email protected]
🌐 www.symbiotec.com ↗

📍 385/2 Pigdamber Near, Mashal Hotel Rau, Indore, Madhya Pradesh, 453331

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Swastik Pipe LimitedSwelect Energy Systems Ltd.Swiggy LimitedSwiss Military Consumer Goods Ltd.Sterling & Wilson Renewable Energy Ltd.Sylvan Plyboard (India) LimitedSymphony LimitedSyncom Formulations (India) Ltd.Syngene International Ltd.Synoptics Technologies LimitedSyrma SGS Technology Ltd.Systango Technologies Ltd.All “S” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search